Joon Hwang, DPM
Podiatrist · Charlottesville, VANPI 1083020267
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Arthrex at 43.4% of the total. Reporting peaked in 2022 at $4,633 and has fallen 98.1% since, to $88 in 2025.
Across 133 payments — averaging $60.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Fortis Surgical, LLC$2K
- Integra Lifesciences Corporation$963
- Organogenesis Inc.$750
- Melinta Therapeutics, LLC$191
- Stryker$147
- plus $509 from 12 others
What the payments were for
- Travel & lodging$2,26128%
- Food & beverage$2,24528%
- Education$3,60044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $3,514 |
| Fortis Surgical, LLC | 6 | $2,031 |
| Integra Lifesciences Corporation | 13 | $963 |
| Organogenesis Inc. | 62 | $750 |
| Melinta Therapeutics, LLC | 9 | $191 |
| Stryker(2 entities) | 6 | $147 |
| KCI USA, Inc. | 3 | $113 |
| Amgen | 1 | $102 |
| Nabriva Therapeutics, PLC | 4 | $62 |
| Trice Medical, Inc. | 2 | $61 |
| Smith+Nephew | 1 | $30 |
| AbbVie | 2 | $29 |
| Tactile Systems Technology Inc | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| Trilliant Surgical LLC. | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,106 in reported general payments places this provider in the 85th percentile of 126 podiatrist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 62 | $1,212 |
| Ammonium Lactate | 50 | $1,028 |
| Diclofenac Sodium | 40 | $748 |
| Gentamicin Sulfate | 22 | $652 |
| Gabapentin | 63 | $572 |
| Ciclopirox | 13 | $536 |
| Doxycycline Hyclate | 71 | $396 |
| Duloxetine Hcl | 29 | $331 |
| SsdSilver Sulfadiazine | 37 | $246 |
| Mupirocin | 43 | $225 |
| Clindamycin Hcl | 36 | $207 |
| Cephalexin | 56 | $156 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $145 |
| Allopurinol | 22 | $141 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $106 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Charlottesville
- Robert BaglioCharlottesville$986
- John ClementsRoanoke$925K
- Leland GilmoreAlexandria$155K
- Justin PhillinganePetersburg$82K
- Jeremy WaltersSuffolk$60K
- Matthew HopsonWilliamsburg$44K
- Benjamin ProtoNewport News$26K
- Kevin RabieVirginia Beach$18K
- Nelson KellerGrafton$17K
- Robert BoguskiRoanoke$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.